Safety and Efficacy of Sirolimus-Eluting Stent in Patients With Acute Coronary Syndrome Undergoing Emergency Procedure

Background Sirolimus-eluting stents (SES) reduce restenosis and revascularization rates, compared with bare-metal stents (BMS), in elective percutaneous coronary intervention (PCI). This study investigated the safety and efficacy of SES for emergency PCI in acute coronary syndrome (ACS) patients. Me...

Full description

Saved in:
Bibliographic Details
Published in:Circulation Journal 2008, Vol.72(7), pp.1054-1058
Main Authors: Nomoto, Kazumiki, Watanabe, Ikuyoshi, Oba, Tomiya, Nagao, Ken, Kushiro, Toshio, Hirayama, Atsushi
Format: Article
Language:English
Subjects:
Acute coronary syndrome
Acute Coronary Syndrome - mortality
Acute Coronary Syndrome - therapy
Aged
Angioplasty, Balloon, Coronary - statistics & numerical data
Disease-Free Survival
Drug-Eluting Stents - adverse effects
Drug-Eluting Stents - statistics & numerical data
Emergency Medical Services
Female
Humans
Immunosuppressive Agents - administration & dosage
Immunosuppressive Agents - adverse effects
Japan - epidemiology
Kaplan-Meier Estimate
Male
Middle Aged
Percutaneous coronary intervention (PCI)
Recurrence
Retrospective Studies
Sirolimus - administration & dosage
Sirolimus - adverse effects
Sirolimus-eluting stent
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Sirolimus-eluting stents (SES) reduce restenosis and revascularization rates, compared with bare-metal stents (BMS), in elective percutaneous coronary intervention (PCI). This study investigated the safety and efficacy of SES for emergency PCI in acute coronary syndrome (ACS) patients. Methods and Results The 154 consecutive patients (SES: n=77, BMS: n=77) admitted to hospital with ACS were enrolled in this study. Procedural success (%DS
ISSN:1346-9843
1347-4820
DOI:10.1253/circj.72.1054